Vik Chopra
Stock Analyst at Wells Fargo
(1.89)
# 3,069
Out of 4,876 analysts
41
Total ratings
35.29%
Success rate
-2.56%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Overweight | $205 → $190 | $166.71 | +13.97% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $12.21 | +6.47% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $73.19 | +2.47% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $52.34 | +8.90% | 4 | May 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $255 → $246 | $187.74 | +31.03% | 2 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $74.63 | +0.50% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $16.00 | +18.75% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $58.82 | +58.11% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $19.65 | +6.87% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $10.94 | +18.83% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $10.90 | +74.31% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $32.26 | +144.89% | 3 | Feb 23, 2024 |
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $166.71
Upside: +13.97%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $12.21
Upside: +6.47%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $73.19
Upside: +2.47%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $52.34
Upside: +8.90%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255 → $246
Current: $187.74
Upside: +31.03%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $74.63
Upside: +0.50%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $16.00
Upside: +18.75%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $58.82
Upside: +58.11%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $19.65
Upside: +6.87%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $10.94
Upside: +18.83%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $10.90
Upside: +74.31%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $32.26
Upside: +144.89%